Modulation of Gut Microbiota by Rifaximin in PD Patients
Clinical trial NCT03958708 · UNKNOWN
Trial details
- NCT number
- NCT03958708
- Sponsor
- Taipei Medical University Shuang Ho Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-13
- Primary completion
- 2020-05-12
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.